Benitec Biopharma Inc. Quarterly Operating Lease, Payments in USD from Q3 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Benitec Biopharma Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q3 2021 to Q3 2024.
  • Benitec Biopharma Inc. Operating Lease, Payments for the quarter ending September 30, 2024 was $73K, a 7.35% increase year-over-year.
  • Benitec Biopharma Inc. annual Operating Lease, Payments for 2024 was $275K, a 9.13% increase from 2023.
  • Benitec Biopharma Inc. annual Operating Lease, Payments for 2023 was $252K, a 28.6% increase from 2022.
  • Benitec Biopharma Inc. annual Operating Lease, Payments for 2022 was $196K, a 2.08% increase from 2021.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $73K +$5K +7.35% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q3 2023 $68K +$6K +9.68% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q3 2022 $62K +$11K +21.6% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-10
Q3 2021 $51K Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.